Literature DB >> 18339971

The use of occupation isoboles for analysis of a response mediated by two receptors: M2 and M3 muscarinic receptor subtype-induced mouse stomach contractions.

Alan S Braverman1, Ronald J Tallarida, Michael R Ruggieri.   

Abstract

Smooth muscle contains multiple muscarinic receptor subtypes, including M2 and M3. M2 receptors outnumber M3 receptors. Based on the potency of subtype selective anticholinergics, contraction is mediated by the M3 subtype. However, results from knockout (KO) mice show that the M2 receptor mediates approximately 45% of the contractile response produced by the M3 receptor. The traditional theory of one receptor mediating a response does not allow assessment of interactions between receptors when more than one receptor participates in a response. Our study was performed using a novel analysis method based on dual receptor occupancy to determine how M2 and M3 receptor subtypes interact to mediate contraction in mouse stomach. Cumulative carbachol concentration contractile responses were determined for wild-type, M2-KO, and M3-KO stomach body smooth muscle. Using affinity constants for carbachol at M2 and M3 cholinergic receptors, the concentration values were converted to fractional receptor occupation. The resulting occupation-effect relations showed maximum effects for the M2 and M3 subtypes, respectively. These occupation-effect relations allow determination of the additive (expected) isobole based on this dual occupancy, thereby providing a curve (mathematically derived) for comparison against the experimentally derived value in wild type. The actual values determined experimentally in the wild type were not statistically significantly different from that predicted by the isobole. This confirms that the interaction between these mutually occupied receptors is additive. The new method of analysis also expands the traditional Schild theory that was based on a single receptor type to which the agonist and antagonist bind.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339971      PMCID: PMC3277794          DOI: 10.1124/jpet.108.137018

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  29 in total

1.  Investigations into the physiological role of muscarinic M2 and M4 muscarinic and M4 receptor subtypes using receptor knockout mice.

Authors:  F P Bymaster; P A Carter; L Zhang; J F Falcone; P W Stengel; M L Cohen; H E Shannon; J Gomeza; J Wess; C C Felder
Journal:  Life Sci       Date:  2001-04-27       Impact factor: 5.037

2.  The problem of synergism and antagonism of combined drugs.

Authors:  S LOEWE
Journal:  Arzneimittelforschung       Date:  1953-06

3.  An overview of drug combination analysis with isobolograms.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2006-05-02       Impact factor: 4.030

Review 4.  Interactions between drugs and occupied receptors.

Authors:  Ronald J Tallarida
Journal:  Pharmacol Ther       Date:  2006-09-07       Impact factor: 12.310

5.  Mice lacking the M3 muscarinic acetylcholine receptor are hypophagic and lean.

Authors:  M Yamada; T Miyakawa; A Duttaroy; A Yamanaka; T Moriguchi; R Makita; M Ogawa; C J Chou; B Xia; J N Crawley; C C Felder; C X Deng; J Wess
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

6.  M(2) and M(4) receptor knockout mice: muscarinic receptor function in cardiac and smooth muscle in vitro.

Authors:  P W Stengel; J Gomeza; J Wess; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

Review 7.  Signal-transduction pathways that regulate visceral smooth muscle function. III. Coupling of muscarinic receptors to signaling kinases and effector proteins in gastrointestinal smooth muscles.

Authors:  William T Gerthoffer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2005-05       Impact factor: 4.052

8.  Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype.

Authors:  M Matsui; D Motomura; H Karasawa; T Fujikawa; J Jiang; Y Komiya; S Takahashi; M M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

9.  M2 mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors.

Authors:  Alan S Braverman; Brett Lebed; Mitchell Linder; Michael R Ruggieri
Journal:  Neurourol Urodyn       Date:  2007       Impact factor: 2.696

10.  Neuronally released acetylcholine acts on the M2 muscarinic receptor to oppose the relaxant effect of isoproterenol on cholinergic contractions in mouse urinary bladder.

Authors:  Frederick J Ehlert; Simon Ahn; Kirk J Pak; Grace J Park; Marline S Sangnil; John A Tran; Minoru Matsui
Journal:  J Pharmacol Exp Ther       Date:  2007-05-01       Impact factor: 4.030

View more
  6 in total

Review 1.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

Review 2.  The application of drug dose equivalence in the quantitative analysis of receptor occupation and drug combinations.

Authors:  Ronald J Tallarida; Robert B Raffa
Journal:  Pharmacol Ther       Date:  2010-05-28       Impact factor: 12.310

3.  Synergistic interaction between the two mechanisms of action of tapentadol in analgesia.

Authors:  W Schröder; T M Tzschentke; R Terlinden; J De Vry; U Jahnel; T Christoph; R J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2011-01-24       Impact factor: 4.030

4.  Comparison of human and porcine gastric clasp and sling fiber contraction by M2 and M3 muscarinic receptors.

Authors:  Anil K Vegesna; Alan S Braverman; Larry S Miller; Ronald J Tallarida; Mansoor I Tiwana; Umar Khayyam; Michael R Ruggieri
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-02-04       Impact factor: 4.052

5.  Quantitation of the contractile response mediated by two receptors: M2 and M3 muscarinic receptor-mediated contractions of human gastroesophageal smooth muscle.

Authors:  Alan S Braverman; Larry S Miller; Anil K Vegesna; Mansoor I Tiwana; Ronald J Tallarida; Michael R Ruggieri
Journal:  J Pharmacol Exp Ther       Date:  2009-01-06       Impact factor: 4.030

6.  Tramadol/paracetamol fixed-dose combination in the treatment of moderate to severe pain.

Authors:  Joseph V Pergolizzi; Mart van de Laar; Richard Langford; Hans-Ulrich Mellinghoff; Ignacio Morón Merchante; Srinivas Nalamachu; Joanne O'Brien; Serge Perrot; Robert B Raffa
Journal:  J Pain Res       Date:  2012-08-29       Impact factor: 3.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.